| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 211,422 | 203,356 | 192,035 | 207,651 | | Cost of Revenue | 71,520 | 64,871 | 63,713 | 66,317 | | | Gross Profit | 139,902 | 138,485 | 128,322 | 141,334 | | | Operating Expenses | | Research Development | 31,542 | 28,829 | 28,809 | 29,948 | | Selling General and Administrative | 71,915 | 67,166 | 62,363 | 67,627 | | Non Recurring | 18,589 | 1,200 | 1,788 | 11,446 | | Others | 13,064 | 6,895 | 14,405 | 13,058 | | | | Total Operating Expenses | 135,110 | 104,090 | 107,365 | 122,079 | | | | Operating Income or Loss | 4,792 | 34,395 | 20,957 | 19,255 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,440 | (3,039) | 11,655 | (12,532) | | Earnings Before Interest And Taxes | 8,232 | 31,356 | 32,612 | 6,723 | | Interest Expense | 3,046 | 2,848 | 2,431 | 5,347 | | Income Before Tax | 5,186 | 28,508 | 30,181 | 1,376 | | Income Tax Expense | 3,456 | 9,027 | 8,146 | 683 | | Minority Interest |
-
|
-
|
-
| 68 | | | | Net Income From Continuing Ops | 1,730 | 19,481 | 22,035 | 761 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,730 | 19,481 | 22,035 | 761 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,730 | $19,481 | $22,035 | $761 |
|
0.13% Nasdaq 
0.34%
Income Statement
